Clicky

Phio Pharmaceuticals Corp.(PHIO)

Description: RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.


Keywords: Biotechnology Life Sciences Biology Rxi Pharmaceuticals

Home Page: www.phiopharma.com

PHIO Technical Analysis

257 Simarano Drive
Marlborough, MA 01752
United States
Phone: 508 767 3861


Officers

Name Title
Mr. Robert J. Bitterman Interim Exec. Chairman
Dr. Geert Cauwenbergh Dr., Med.Sc., Ph.D. Interim Principal Exec. & Financial Officer and Director
Ms. Caitlin Kontulis VP of Fin. & Admin. and Sec.

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0.2318
Trailing PE: 0
Price-to-Book MRQ: 0.3842
Price-to-Sales TTM: 48.0082
IPO Date: 2012-05-10
Fiscal Year End: December
Full Time Employees: 12
Back to stocks